Evidence map›Paper›PMID 31548652›Full record

ArticleScientific reports2019

Characterization of drug resistance and genetic diversity of Plasmodium falciparum parasites from Tripura, Northeast India.

S J Patgiri, K Sarma, N Sarmah, N Bhattacharyya, D K Sarma, T Nirmolia, D R Bhattacharyya, P K Mohapatra, D Bansal, P K Bharti and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Genetic diversity ofCurrent research in parasitology & vector-borne diseases · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Molecular detection of drug-resistantThe Indian journal of medical research · 2023
    Article
  9. Article
  10. Genetic polymorphism ofAccess microbiology · 2022
    Article
  11. Multi-Omics Advancements towardsDiagnostics (Basel, Switzerland) · 2021
    Review
  12. Evidence of a Recent Bottleneck inPathogens (Basel, Switzerland) · 2021
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

S J PatgiriICMR - Regional Medical Research Centre, North East Region, Dibrugarh, Assam, India. saurav.patgiri@gmail.com.ORCID http://orcid.org/0000-0003-0651-2739
K SarmaICMR - Regional Medical Research Centre, North East Region, Dibrugarh, Assam, India.
N SarmahICMR - Regional Medical Research Centre, North East Region, Dibrugarh, Assam, India.
N BhattacharyyaICMR - Regional Medical Research Centre, North East Region, Dibrugarh, Assam, India.
D K SarmaICMR - Regional Medical Research Centre, North East Region, Dibrugarh, Assam, India.
T NirmoliaICMR - Regional Medical Research Centre, North East Region, Dibrugarh, Assam, India.
D R BhattacharyyaICMR - Regional Medical Research Centre, North East Region, Dibrugarh, Assam, India.
P K MohapatraICMR - Regional Medical Research Centre, North East Region, Dibrugarh, Assam, India.
D BansalDepartment of Microbiology and Immunology, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.ORCID http://orcid.org/0000-0002-1387-4335
P K BhartiICMR - National Institute for Research in Tribal Health, Jabalpur, Madhya Pradesh, India.
R SehgalDepartment of Medical Parasitology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
J MahantaICMR - Regional Medical Research Centre, North East Region, Dibrugarh, Assam, India.
A A SultanDepartment of Microbiology and Immunology, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
Regional Medical Research Centre · INMinistry of Public Health · QANational Institute for Research in Tribal Health · INPost Graduate Institute of Medical Education and Research · INWeill Cornell Medical College in Qatar · QA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Monitoring of anti-malarial drug resistance is vital in Northeast India as this region shares its international border with Southeast Asia. Genetic diversity of Plasmodium parasites regulates transmission dynamics, disease severity and vaccine efficacy. P. falciparum chloroquine resistance transporter (Pfcrt), multidrug resistance-1 (Pfmdr-1) and kelch 13 propeller (PfK-13) genes which govern antimalarial drug resistance and three genetic diversity markers, merozoite surface protein 1 and 2 (Pfmsp-1, Pfmsp-2) and glutamate rich protein (Pfglurp) were evaluated from Tripura, Northeast India using molecular tools. In the Pfcrt gene, 87% isolates showed triple mutations at codons M74I, N75E and K76T. 12.5% isolates in Pfmdr-1 gene showed mutation at N86Y. No polymorphism in PfK-13 propeller was found. Polyclonal infections were observed in 53.85% isolates and more commonly in adults (p = 0.0494). In the Pfmsp-1 locus, the K1 allelic family was predominant (71.2%) followed by the 3D7/IC family (69.2%) in the Pfmsp-2 locus. RII region of Pfglurp exhibited nine alleles with expected heterozygosity of 0.85. The multiplicity of infection for Pfmsp-1, Pfmsp-2 and Pfglurp were 1.56, 1.31 and 1.06 respectively. Overall, the study demonstrated a high level of chloroquine resistance and extensive parasite diversity in the region, necessitating regular surveillance in this population group.

Indexed as

MutationAntimalarialsChloroquineDrug ResistanceGenetic VariationIndiaMalaria, FalciparumPlasmodium falciparumAntimalarialsChloroquine

Identifiers

PMID31548652
PMCPMC6757058
OpenAlexW2974310147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.